Get the Stockscreener App
211.23
0.28%
0.53
Overview
News
Price History
Option Chain
Financials
Why WST Down?
Discussions
Forecast
Stock Split
Dividend History
West Pharmaceutical Services Inc stock is traded at $211.23, with a volume of 78,561.
It is up +0.28% in the last 24 hours and down -8.18% over the past month.
West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
See More
Previous Close:
$210.70
Open:
$213.58
24h Volume:
78,561
Relative Volume:
0.08
Market Cap:
$15.25B
Revenue:
$2.88B
Net Income/Loss:
$499.60M
P/E Ratio:
31.34
EPS:
6.74
Net Cash Flow:
$321.60M
1W Performance:
+4.87%
1M Performance:
-8.18%
6M Performance:
-28.46%
1Y Performance:
-44.40%
1-Day Range:
$209.31
$213.58
1-Week Range:
$187.43
$213.58
52-Week Range:
$187.43
$394.42
West Pharmaceutical Services Inc Stock (WST) Company Profile
Name
West Pharmaceutical Services Inc
Sector
Industry
Phone
(610) 594-2900
Address
530 HERMAN O. WEST DRIVE, EXTON, PA
Compare WST with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
211.26 | 15.25B | 2.88B | 499.60M | 321.60M | 6.74 |
|
ISRG
Intuitive Surgical Inc
|
498.39 | 161.79B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
204.95 | 58.55B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
91.28 | 44.45B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
214.52 | 31.42B | 4.93B | 1.25B | 1.38B | 8.47 |
|
COO
The Cooper Companies, Inc.
|
78.28 | 15.45B | 3.90B | 392.30M | 288.10M | 1.95 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-18-25 | Initiated | Evercore ISI | Outperform |
| Feb-14-25 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-08-25 | Initiated | Citigroup | Buy |
| Dec-13-24 | Initiated | Wolfe Research | Peer Perform |
| Dec-12-24 | Upgrade | UBS | Neutral → Buy |
| Feb-07-24 | Upgrade | Jefferies | Hold → Buy |
| Jun-16-23 | Upgrade | BofA Securities | Neutral → Buy |
| Apr-11-23 | Upgrade | Stephens | Equal-Weight → Overweight |
| Dec-14-22 | Initiated | Deutsche Bank | Hold |
| Nov-30-22 | Initiated | UBS | Neutral |
| Oct-28-22 | Downgrade | BofA Securities | Buy → Neutral |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Oct-14-20 | Initiated | Stephens | Equal-Weight |
| Jul-21-20 | Upgrade | BofA Securities | Neutral → Buy |
| Apr-24-20 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Dec-12-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jul-26-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| May-01-19 | Downgrade | Jefferies | Buy → Hold |
| Apr-23-19 | Initiated | William Blair | Outperform |
| Apr-25-18 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jan-24-18 | Initiated | Goldman | Neutral |
| Oct-17-17 | Downgrade | BofA/Merrill | Buy → Neutral |
| Oct-03-17 | Initiated | Stephens | Equal-Weight |
| Sep-15-17 | Upgrade | Jefferies | Hold → Buy |
| Oct-28-16 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Sep-21-16 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Mar-22-16 | Initiated | Wells Fargo | Outperform |
| May-14-10 | Reiterated | UBS | Neutral |
| Feb-23-10 | Initiated | Jefferies & Co | Buy |
| Dec-19-08 | Initiated | UBS | Neutral |
View All
West Pharmaceutical Services Inc Stock (WST) Latest News
Wellington Management Group LLP Buys 99 Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - Defense World
West Pharmaceutical Services to Announce Q1 2025 Results with Live Webcast and Q&A Session - MSN
West Pharmaceutical Services Earnings Preview: What to Expect - MSN
West Pharmaceutical Services, Inc.'s (NYSE:WST) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? - Yahoo Finance
Zacks Research Analysts Reduce Earnings Estimates for WST - Defense World
College lab named in honor of West Pharmaceutical Services - Pennsylvania College of Technology
The Latest Breaking News on West Pharmaceutical Services Earnings Preview: What to Expect - inkl
West Pharmaceutical Services Earnings Preview: What To Expect - Barchart.com
West to Host First-Quarter 2025 Conference Call - The Malaysian Reserve
Mark Your Calendar: West Pharmaceutical Announces Critical Q1 2025 Earnings Date - Stock Titan
Will Weakness in West Pharmaceutical Services, Inc.'s (NYSE:WST) Stock Prove Temporary Given Strong Fundamentals? - simplywall.st
West Pharmaceutical Services, Inc. Investigated Regarding Potential Securities Law ViolationsContact Levi & Korsinsky for DetailsWST - ACCESS Newswire
West Pharmaceutical stock hits 52-week low at $196.78 - Investing.com Australia
West Pharmaceutical stock hits 52-week low at $196.78 By Investing.com - Investing.com India
Analysis of China-to-West pharmaceutical licensing deals in 2024 - Nature
ATTENTION WST SHAREHOLDERS: Investors who Lost Money on West Pharmaceutical Services, Inc. are Urged to Contact Levi & Korsinsky About an Ongoing Investigation - ACCESS Newswire
Trump administration shutters DC foreign policy think tank Wilson Center - MarketScreener
Teacher Retirement System of Texas Takes Position in West Pharmaceutical Services, Inc. (NYSE:WST) - Defense World
West Pharmaceutical Services, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud AllegationsWST - ACCESS Newswire
National Wealth Management Group LLC Makes New $706,000 Investment in West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
Pharmaceutical Testing Services Market Set to Witness - openPR.com
Delcath Systems (NASDAQ:DCTH) and West Pharmaceutical Services (NYSE:WST) Critical Survey - Defense World
WST ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your West Pharmaceutical Services, Inc. investment - ACCESS Newswire
Commonwealth Equity Services LLC Trims Stake in West Pharmaceutical Services, Inc. (NYSE:WST) - Defense World
How Is The Market Feeling About West Pharmaceutical Servs? - Benzinga
West Pharmaceutical Services, Inc. (WST) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights - ACCESS Newswire
Unpacking Q4 Earnings: West Pharmaceutical Services (NYSE:WST) In The Context Of Other Drug Development Inputs & Services Stocks - Yahoo Finance
West Pharmaceutical Services, Inc. (NYSE:WST) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World
West Pharmaceutical Services: Bylaw Changes and Share Price Dynamics - AInvest
West Pharmaceutical Services (NYSE:WST) Proposes Bylaw Changes; Share Price Remains Flat - Yahoo Finance
Is West Pharmaceutical Services Stock Underperforming the S&P 500? - Nasdaq
Is West Pharmaceutical Services Stock Underperforming The S&P 500? - Barchart.com
West Pharmaceutical at KeyBanc Forum: Strategic Growth Amid Challenges - Investing.com
West Pharmaceutical at KeyBanc Forum: Strategic Growth Amid Challenges By Investing.com - Investing.com UK
UBS maintains Buy on West Pharma, reiterates $285 target By Investing.com - Investing.com Canada
UBS maintains Buy on West Pharma, reiterates $285 target - Investing.com
Did West Pharmaceutical Services, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate- WST - ACCESS Newswire
This West Pharmaceutical Services Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga
Evercore ISI sets $275 target on West Pharmaceutical stock - Investing.com
Evercore ISI sets $275 target on West Pharmaceutical stock By Investing.com - Investing.com UK
Evercore ISI Initiates West Pharmaceutical Services at Outperform With $275 Price Target - MarketScreener
Managing Risks In Injectable Drug Delivery Solutions For Todays Drug Products And Tomorrows Novel Applications - Bioprocess Online
West Pharmaceutical at Barclays Healthcare: Strategic Growth Amid Challenges - Investing.com India
West Pharmaceutical at Barclays Healthcare: Strategic Growth Amid Challenges By Investing.com - Investing.com South Africa
West Pharmaceutical Services, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your RightsWST - ACCESS Newswire
On-Body Drug Delivery Devices Market to Hit $ 82.74 Bn by 2033Key - openPR
Jones Financial Companies Lllp Grows Stock Position in West Pharmaceutical Services, Inc. (NYSE:WST) - Defense World
West Pharmaceutical Announces Leadership Transition - TipRanks
Meeting Annex 1 Regulations: A Proactive Approach To Regulatory Compliance - Med Device Online
West Pharmaceutical Services Inc Stock (WST) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):